Abstract
Fermented dairy products like kefir have a global attention because its consumption and associated benefits supports intestinal health, however, its determinants remain understudied in emerging markets such as Ecuador. We, therefore, evaluated kefir consumption (in mL) retrospectively, and the perceived benefits, as well as consumer`s knowledge, attitudes and practices among 500 adult consumers. Intestinal improvements were measured via a reliable 5-item Likert scale (Cronbach’s α = 0.714) and the Bristol Stool Scale. Latent class analysis and qualitative evaluation identified consumer profiles and behavioral drivers. We found that daily kefir intake increased significantly from 99.9 mL to 172.8 mL over three weeks (p < 0.05), resulting on a long-term habitual intake of 136 mL/day across age and gender. Evident improvements were reported across five digestive parameters: abdominal pain, bloating, inflammation, acid reflux, and bowel regularity. Bristol Scores significantly improved (+0.73 points, p < 0.05; to Type 4). Social media and recommendations by health professional drove initial engagement, whereas consumption and validation of functional benefits sustained long-term habits. Taste is a temporary barrier, but high product price emerged as a barrier to regular intake. Regular consumption of a glass of kefir could significantly improve gastrointestinal health, mainly reducing abdominal pain.